Polycystic Ovary Syndrome Clinical Trial
Official title:
Proteomics & Glyco-Proteomic Analysis of Follicular Fluid Derived From Health Patient/Donors and Polycystic Ovary Syndrome Patients
To the best of the investigators knowledge, exhaustive characterization of the low and high
abundant proteins and glyco-proteins of the Follicular Fluid (FF) has not yet been achieved.
Such an analysis may provide critical molecular data on the role of the FF in oocyte
maturation and may identify specific changes in the FF proteome of patients with gynecologic
problems, such as Polycystic Ovary Syndrome (PCOS).
Specific Aims
1. To perform a comprehensive analysis of normal human FF using sensitive mass
spectrometry in combination with conventional approaches for proteomic evaluation and
using HPLC and Western blot for glyco-proteomic analysis.
2. Characterize differential proteomic and glyco-proteomic patterns of the FF in normal
women compared to lean and obese women with PCOS.
3. To supplement the differential proteomic and glyco-proteomic analysis with steroid
hormone analysis in all FF samples.
In this study, we plan to utilize ultrasensitive mass spectrometry (MS) and other
conventional proteomic approaches to identify the low and high abundant proteins present in
human FF. Additionally, we plan to use high-performance liquid chromatography (HPLC) and
Western blot techniques to evaluate the Neu5Gc and glycan array based ELISA techniques to
detect anti-Neu5Gc antibody profile in human FF. This analysis will be performed on FF
samples obtained from normal women undergoing In-Vitro Fertilization and Embryo Transfers
(IVF-ET) for a male factor alone and oocyte donors from our 3rd Party Reproduction Program
and from lean and obese women with PCOS. This study will provide information on protein,
glycoprotein, and steroid hormone expression during normal folliculogenesis and during the
pathologic condition of PCOS, which should also provide basic scientific information on
normal and abnormal oocyte development.
Human FF bathes the developing oocyte. Previous studies indicate that the FF contains
cytokines, steroidal and protein hormones, and growth factors. The presence of proteins with
such significant biological properties implies a paracrine and autocrine role for the FF in
promoting normal oocyte development. Furthermore, the presence of any antigenic sialic acid
Neu5Gc and the presence of antibodies targeting these antigenic glycoconjugates (glycolipid
and glycoproteins decorated with sialic acid) may interfere with oocyte development,
hormonal expression, fertilization, and possibly implantation. Here we hypothesize that an
exhaustive proteomic and glyco-proteomic characterization of human FF is essential for a
thorough understanding of its biological significance. We also hypothesize that PCOS may
have differential expression of the FF protein and glyco-protein milieu, and that the
expression may differ further between lean and obese women with PCOS. PCOS represents a
heterogeneous disorder. The severity of hyperandrogensim, metabolic and menstrual
disturbance, and obesity is variable with up to 40% not clinically expressing signs of
classic hyperandrogenism. On the other hand, these atypical, often lean, PCOS women can have
impaired glucose tolerance and diabetes. Reports suggest that these lean PCOS women have
altered serum IGFBP-1, a characteristic endocrine feature of patients with obese PCOS, and
related to hyperinsulinemia and/or obesity. The lean phenotype of PCOS and its significance
is unclear but may represent a cryptic or unexpressed form of PCOS or may be a prelude to
individuals who will later manifest clinical signs of obese/overweight PCOS. Changes in
expression may be expected because of the different amounts of steroidal hormones and
inflammatory markers in the FF derived from women with PCOS.
;
Observational Model: Case Control, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03142633 -
MicroRNA as Biomarkers for Development of Metabolic Syndrome in Women With Polycystic Ovary Syndrome
|
||
Completed |
NCT06158932 -
A Single Group Study to Evaluate the Effects of a Myo-Inositol and D-Chiro Inositol Supplement on Symptoms Associated With Polycystic Ovary Syndrome and Hormone Imbalance
|
N/A | |
Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
Active, not recruiting |
NCT02500147 -
Metformin for Ectopic Fat Deposition and Metabolic Markers in Polycystic Ovary Syndrome (PCOS)
|
Phase 4 | |
Completed |
NCT04932070 -
Berberine and Polycystic Ovary Syndrome
|
N/A | |
Suspended |
NCT03652987 -
Endocrine and Menstrual Disturbances in Women With Polycystic Ovary Syndrome (PCOS)
|
||
Completed |
NCT03480022 -
Liraglutide 3mg (Saxenda) on Weight, Body Composition, Hormonal and Metabolic Parameters in Obese Women With PCOS
|
Phase 3 | |
Active, not recruiting |
NCT03043924 -
Functional Study of the Hypothalamus in Magnetic Resonance Imaging (MRI) in Polycystic Ovary Syndrome (PCOS)
|
N/A | |
Completed |
NCT05246306 -
Aerobic Capacity and Physical Fitness Level of Adolescents With PCOS
|
||
Completed |
NCT05981742 -
Effects of Combined Metformin and Cabergoline in Comparison With Metformin Only Therapy on Ovarian and Hormonal Activities in Iraqi Patients With PCOS
|
Phase 2 | |
Completed |
NCT05702957 -
Letrozole vs Clomiphene Citrate for Induction of Ovulation in Women With Polycystic Ovarian Syndrome
|
Phase 2/Phase 3 | |
Completed |
NCT05029492 -
Effect of Visceral Manipulation on PCOS
|
N/A | |
Not yet recruiting |
NCT02255578 -
Endobarrier Treatment in Women With PCOS
|
Phase 3 | |
Completed |
NCT02924025 -
Motivational Interviewing as an Intervention for PCOS
|
N/A | |
Withdrawn |
NCT01638988 -
Clomifene Citrate Versus Metformin in First-line Treatment of Infertility in Patients With Polycystic Ovary Syndrome and a Resistance to Insulin
|
Phase 3 | |
Not yet recruiting |
NCT00883259 -
Metformin and Gestational Diabetes in High-risk Patients: a RCTs
|
Phase 4 | |
Completed |
NCT02098668 -
Mathematical Model for the Human Menstrual Cycle, Endocrinological Diseases and Fertility Treatment-PAEON
|
N/A | |
Completed |
NCT01462864 -
Development of a Structured Education Programme for Women With Polycystic Ovary Syndrome
|
N/A | |
Recruiting |
NCT01431352 -
Letrozole Versus Chinese Herbal Medicine on Polycystic Ovary Syndrome (PCOS)
|
N/A | |
Completed |
NCT00989781 -
Mechanisms of Increased Androgen Production Among Women With Polycystic Ovary Syndrome
|
N/A |